Equities

Solar Foods Oyj

Solar Foods Oyj

Actions
Consumer Staples Food Producers
  • Price (EUR)5.06
  • Today's Change0.08 / 1.61%
  • Shares traded2.95k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 10:26 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Solar Foods Oy is a Finland-based food technology company. It is engaged in the sustainable protein production, solving the global food production problem by offering a completely new alternative to existing animal and plant proteins. Solar Food's product is the naturally occurring single-cell protein Solein, which can be used as a food raw material with high protein content. The bioprocess takes a single microbe, one of the billion different ones found in nature, and grows it by fermenting it using air and electricity. Solein is a new food that requires regulatory approval before it can be sold and used in foods. Solein got food regulatory approval in Singapore, European Union and in the United Kingdom.

  • Revenue in EUR (TTM)17.32k
  • Net income in EUR-10.69m
  • Incorporated2017
  • Employees40.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nanoform Finland Oyj2.29m-21.67m95.79m174.00--1.35--41.75-0.2707-0.27070.02850.8290.026997.306.2713,906.00-25.39-27.13-27.55-29.48-631.53-604.26-944.30-1,023.708.12--0.0778---26.4161.315.98--53.92--
Diamyd Medical AB11.20k-13.08m110.63m27.00--8.68--9,876.66-1.60-1.600.00141.460.0006--3.174,814.82-71.82-34.32-83.67-38.45-10,161.54-3,111.20-116,806.90-17,499.13----0.1737---76.19-39.23-30.82------
Cereno Scientific AB0.00-5.99m118.87m5.00--5.46-----0.283-0.2830.000.89980.00----0.00-23.45-16.81-25.41-18.26-----------9.440.1519-------73.95--44.79--
Nightingale Health Oyj4.36m-17.46m120.88m86.00--2.18--27.74-0.2895-0.28950.07221.370.04412.333.4650,674.42-17.67-14.59-18.99-15.9966.4577.90-400.71-435.739.74--0.0308--4.2116.133.43--8.54--
Solar Foods Oyj17.32k-10.69m122.71m40.00--4.34--7,085.01-0.4438-0.44380.00071.150.0004--0.0049558.71-21.32---24.11--20,183.14---61,719.29-----2.710.4266-------66.44------
XSpray Pharma AB (publ)0.00-22.23m140.31m24.00--2.56-----7.81-7.810.0017.140.00----0.00-37.64-18.38-40.48-19.26--------1.51--0.0543-------36.45--2.87--
Egetis Therapeutics AB (publ)6.82m-25.49m160.33m33.00--4.76--23.50-1.07-1.070.28821.090.142523.003.612,933,333.00-48.67-33.02-61.23-36.4685.48---341.54-357.720.9808-19.710.2605--154.8715.35-68.68------
Vicore Pharma Holding AB8.98m-16.93m165.53m29.00--2.42--18.43-1.72-1.720.91353.380.2045--43.734,343,459.00-38.54-58.65-41.49-65.58-----188.45------0.00-------7.81------
Data as of Nov 14 2024. Currency figures normalised to Solar Foods Oyj's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.